Phase 2
N=127
Does a Transabdominal Plane Block Decrease Patient Pain After Ventral Hernia Repair?
Ventral Hernia · Umbilical Hernia · Incisional Hernia · Postoperative Complications · Pain, Postoperative
Bottom Line
View on ClinicalTrials.gov: NCT02007096 ↗Enrolled (actual)
127
Serious AEs
—
Results posted
Jan 2018
Primary outcome: Primary: Post-operative Opioid Use — 10.59; 15.62; 16.09; 32.24 mg
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Transabdominal Plane Block (Drug); Non Transabdominal Plane Block (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Primary completion
- Oct 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Post-operative Opioid Use |
10.59; 15.62; 16.09; 32.24; 20.70; 39.37 | — |
| SECONDARY Pain Score |
4.60; 4.52; 6.75; 6.98 | — |
| SECONDARY Operating Procedure Time |
97.41; 98.81 | — |
| SECONDARY Pain Score |
4.60; 4.52; 6.75; 6.98 | — |
Summary
The purpose of this study is to determine if a Transabdominal Plane Block will decrease patient pain and pain medication use after a laparoscopic ventral (ventral, umbilical, incisional) hernia repair with mesh.
Eligibility Criteria
Inclusion Criteria
- age 18 and older
- elective laparoscopic ventral (ventral, umbilical, incisional) hernia repair at Mount Sinai Hospital
Exclusion Criteria
- age younger than 18
- allergic reaction to bupivacaine
- allergic reaction to opioids
- opioid substance abuse
Data sourced from ClinicalTrials.gov (NCT02007096). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.